Statement of Changes in Beneficial Ownership (4)
20 Mai 2022 - 10:27PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Pendleton Todd |
2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc.
[
DLB
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP, Chief Marketing Officer |
|
(Last)
(First)
(Middle)
C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET |
3. Date of Earliest Transaction
(MM/DD/YYYY)
5/18/2022 |
|
(Street)
SAN FRANCISCO, CA 94103
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Class A Common Stock | 5/18/2022 | | M | | 6750 | A | $64.60 | 44538 (1) | D | |
| Class A Common Stock | 5/18/2022 | | S | | 6750 | D | $75.9371 (2) | 37788 (1) | D | |
| Class A Common Stock | 5/18/2022 | | M | | 23437 | A | $62.43 | 61225 (1) | D | |
| Class A Common Stock | 5/18/2022 | | S | | 23437 | D | $75.4685 (3) | 37788 (1) | D | |
| Class A Common Stock | 5/18/2022 | | M | | 2113 | A | $68.40 | 39901 (1) | D | |
| Class A Common Stock | 5/18/2022 | | S | | 2113 | D | $75.1404 (4) | 37788 (1) | D | |
| Class A Common Stock | 5/18/2022 | | M | | 13500 | A | $64.60 | 51288 (1) | D | |
| Class A Common Stock | 5/18/2022 | | S | | 13500 | D | $75.0216 (5) | 37788 (1) | D | |
| Class A Common Stock | 5/19/2022 | | M | | 5813 | A | $68.40 | 43601 (1) | D | |
| Class A Common Stock | 5/19/2022 | | S | | 5813 | D | $75.80 (6) | 37788 (1) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Employee Stock Option (right to buy) | $64.60 | 5/18/2022 | | M | | | 6750 | (7) | 12/17/2028 | Class A Common Stock | 6750 | $0.00 | 5250 | D | |
| Employee Stock Option (right to buy) | $62.43 | 5/18/2022 | | M | | | 23437 | (8) | 7/16/2028 | Class A Common Stock | 23437 | $0.00 | 5209 | D | |
| Employee Stock Option (right to buy) | $68.40 | 5/18/2022 | | M | | | 2113 | (9) | 12/16/2029 | Class A Common Stock | 2113 | $0.00 | 22548 | D | |
| Employee Stock Option (right to buy) | $64.60 | 5/18/2022 | | M | | | 13500 | (10) | 12/17/2025 | Class A Common Stock | 13500 | $0.00 | 0 | D | |
| Employee Stock Option (right to buy) | $68.40 | 5/19/2022 | | M | | | 5813 | (9) | 12/16/2029 | Class A Common Stock | 5813 | $0.00 | 16735 | D | |
| Explanation of Responses: |
| (1) | Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest. |
| (2) | The shares were sold in multiple transactions at prices ranging from $75.77 to $76.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| (3) | The shares were sold in multiple transactions at prices ranging from $75.155 to $75.76, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| (4) | The shares were sold in multiple transactions at prices ranging from $75.13 to $75.15, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| (5) | The shares were sold in multiple transactions at prices ranging from $75.00 to $75.12, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| (6) | The shares were sold in multiple transactions at prices ranging from $75.73 to $75.86, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| (7) | This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. |
| (8) | This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. |
| (9) | This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. |
| (10) | This performance-based stock option award was granted for a total of 18,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 13,500 shares. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Pendleton Todd
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO, CA 94103 |
|
| SVP, Chief Marketing Officer |
|
Signatures
|
| /s/ Daniel Rodriguez, Attorney-in-Fact for Todd Pendleton | | 5/20/2022 |
| **Signature of Reporting Person | Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
Dolby Laboratories (NYSE:DLB)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Dolby Laboratories (NYSE:DLB)
Historical Stock Chart
Von Apr 2023 bis Apr 2024
